• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对初级保健临床医生进行行为减肥咨询转诊的评估。

An Evaluation of Primary Care Clinician Referrals for Behavioral Weight Loss Counseling.

作者信息

Saraiya Veeral M, Berkowitz Seth A, Johnston Larry F, Couper David J, Sotres-Alvarez Daniela, Lyons Kiira M, Thaxton Cheyenne K, Skinner Harlyn G, Samuel-Hodge Carmen D, Keyserling Thomas C

机构信息

University of North Carolina at Chapell Hill, Chapell Hill, NC, USA.

出版信息

J Prim Care Community Health. 2024 Jan-Dec;15:21501319241308054. doi: 10.1177/21501319241308054.

DOI:10.1177/21501319241308054
PMID:39690977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11653456/
Abstract

INTRODUCTION/OBJECTIVES: In the context of enrolling patients from primary care practices into a weight loss research study, this study describes the percentage of patients primary care clinicians (PCCs) considered appropriate for referral and study participation rates among those referred.

METHODS

An electronic health record review identified 5322 patients aged 18 to 75 years with BMI ≥ 30 kg/m as eligible for review by community, attending, and resident PCCs for referral to a weight loss study. Referrals and patient interest in participating in the study are reported overall and by PCC type.

RESULTS

The mean (SD) age was 53.1 (13.9) years, mean BMI 36.5 (6.2) kg/m, 41.5% were male, and 30.9% were African American. PCCs reviewed 3882 patients and referred 2762 (71.1%) to the study. Of 1120 not referred, 260 (23.2%) were not known well enough by PCCs to assess for referral. The most common reasons for not referring included too much comorbidity (171, 15.3%), psychological reasons (170, 15.2%), and non-English speaking (125, 11.2%). Among 1897 patients invited to participate, 676 (35.6%) expressed interest and 360 (19.0%) were enrolled.

CONCLUSIONS

PCCs referred 71.1% of their eligible patients. Among those referred, interest in participation was modest and enrollment was low.

TRIAL REGISTRATION

ClinicalTrials.gov Identifier: NCT04302727.

摘要

引言/目的:在将初级保健机构的患者纳入一项减肥研究的背景下,本研究描述了初级保健临床医生(PCC)认为适合转诊的患者百分比以及被转诊患者的研究参与率。

方法

通过电子健康记录审查,确定了5322名年龄在18至75岁、BMI≥30kg/m²的患者,社区、主治和住院PCC可对其进行审查,以转诊至减肥研究。总体以及按PCC类型报告转诊情况和患者参与研究的意愿。

结果

平均(标准差)年龄为53.1(13.9)岁,平均BMI为36.5(6.2)kg/m²,41.5%为男性,30.9%为非裔美国人。PCC审查了3882名患者,其中2762名(71.1%)被转诊至该研究。在未被转诊的1120名患者中,260名(23.2%)PCC对其了解不足无法评估是否适合转诊。未转诊的最常见原因包括合并症过多(171例,15.3%)、心理原因(170例,15.2%)和非英语使用者(125例,11.2%)。在1897名受邀参与的患者中,676名(35.6%)表示有兴趣,360名(19.0%)登记参与。

结论

PCC将71.1%符合条件的患者转诊。在被转诊的患者中,参与意愿一般,登记参与率较低。

试验注册

ClinicalTrials.gov标识符:NCT04302727。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb7/11653456/50e18985827e/10.1177_21501319241308054-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb7/11653456/8001230a0b4b/10.1177_21501319241308054-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb7/11653456/50e18985827e/10.1177_21501319241308054-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb7/11653456/8001230a0b4b/10.1177_21501319241308054-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb7/11653456/50e18985827e/10.1177_21501319241308054-fig2.jpg

相似文献

1
An Evaluation of Primary Care Clinician Referrals for Behavioral Weight Loss Counseling.对初级保健临床医生进行行为减肥咨询转诊的评估。
J Prim Care Community Health. 2024 Jan-Dec;15:21501319241308054. doi: 10.1177/21501319241308054.
2
Mobile health (m-health) smartphone interventions for adolescents and adults with overweight or obesity.移动健康(m-health)智能手机干预措施用于超重或肥胖的青少年和成年人。
Cochrane Database Syst Rev. 2024 Feb 20;2(2):CD013591. doi: 10.1002/14651858.CD013591.pub2.
3
Effect of a Lifestyle Intervention on Cardiometabolic Health Among Emerging Adults: A Randomized Clinical Trial.生活方式干预对成年早期人心血管代谢健康的影响:一项随机临床试验。
JAMA Netw Open. 2022 Sep 1;5(9):e2231903. doi: 10.1001/jamanetworkopen.2022.31903.
4
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.孕期超重或肥胖女性使用二甲双胍以改善母婴结局。
Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. doi: 10.1002/14651858.CD010564.pub2.
5
Hormonal contraceptives for contraception in overweight or obese women.超重或肥胖女性避孕用激素避孕药。
Cochrane Database Syst Rev. 2013 Apr 30(4):CD008452. doi: 10.1002/14651858.CD008452.pub3.
6
Hormonal contraceptives for contraception in overweight or obese women.超重或肥胖女性避孕用激素避孕药
Cochrane Database Syst Rev. 2016 Aug 18;2016(8):CD008452. doi: 10.1002/14651858.CD008452.pub4.
7
Interventions to change the behaviour of health professionals and the organisation of care to promote weight reduction in children and adults with overweight or obesity.改变卫生专业人员行为及护理组织方式的干预措施,以促进超重或肥胖儿童及成人减轻体重。
Cochrane Database Syst Rev. 2017 Nov 30;11(11):CD000984. doi: 10.1002/14651858.CD000984.pub3.
8
An Adaptive Behavioral Intervention for Weight Loss Management: A Randomized Clinical Trial.适应行为干预在体重管理中的应用:一项随机临床试验。
JAMA. 2024 Jul 2;332(1):21-30. doi: 10.1001/jama.2024.0821.
9
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
10
Patient-Delivered Continuous Care for Weight Loss Maintenance: A Randomized Clinical Trial.患者自我持续护理以维持体重减轻:一项随机临床试验。
JAMA Intern Med. 2025 May 27. doi: 10.1001/jamainternmed.2025.1345.

本文引用的文献

1
Associations between comfort eating and weight change during the COVID-19 pandemic among U.S. adults.美国成年人在新冠疫情期间情绪性暴饮暴食与体重变化之间的关联。
Hum Nutr Metab. 2023 Sep 1;33. doi: 10.1016/j.hnm.2023.200212.
2
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.司美格鲁肽在肥胖但无糖尿病患者中的心血管结局。
N Engl J Med. 2023 Dec 14;389(24):2221-2232. doi: 10.1056/NEJMoa2307563. Epub 2023 Nov 11.
3
Long-term cancer outcomes after bariatric surgery.减重手术后的长期癌症结果。
Obesity (Silver Spring). 2023 Sep;31(9):2386-2397. doi: 10.1002/oby.23812.
4
Tirzepatide Once Weekly for the Treatment of Obesity.司美格鲁肽每周一次治疗肥胖症。
N Engl J Med. 2022 Jul 21;387(3):205-216. doi: 10.1056/NEJMoa2206038. Epub 2022 Jun 4.
5
Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial.地中海饮食与低脂饮食用于心血管疾病的长期二级预防(CORDIOPREV):一项随机对照试验。
Lancet. 2022 May 14;399(10338):1876-1885. doi: 10.1016/S0140-6736(22)00122-2. Epub 2022 May 4.
6
COVID-19 pandemic and weight gain in American adults: A nationwide population-based study.新冠疫情大流行期间美国成年人的体重增加:一项基于全国人口的研究。
Diabetes Metab Syndr. 2022 Jan;16(1):102392. doi: 10.1016/j.dsx.2022.102392. Epub 2022 Jan 10.
7
Social Isolation and Loneliness During the COVID-19 Pandemic: Impact on Weight.新冠疫情期间的社交隔离与孤独感:对体重的影响
Curr Obes Rep. 2021 Sep;10(3):365-370. doi: 10.1007/s13679-021-00447-9. Epub 2021 Jul 23.
8
US national trends in bariatric surgery: A decade of study.美国肥胖症手术的国家趋势:十年研究。
Surgery. 2021 Jul;170(1):13-17. doi: 10.1016/j.surg.2021.02.002. Epub 2021 Mar 11.
9
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial.司美格鲁肽 2·4 毫克每周一次治疗超重或肥胖、以及 2 型糖尿病成人患者(STEP 2):一项随机、双盲、双模拟、安慰剂对照、3 期临床试验。
Lancet. 2021 Mar 13;397(10278):971-984. doi: 10.1016/S0140-6736(21)00213-0. Epub 2021 Mar 2.
10
Once-Weekly Semaglutide in Adults with Overweight or Obesity.每周一次司美格鲁肽在超重或肥胖成人中的应用。
N Engl J Med. 2021 Mar 18;384(11):989-1002. doi: 10.1056/NEJMoa2032183. Epub 2021 Feb 10.